7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $463M | -$38M | 6.7% | -5.4% | -$75M | — | $12M |
| 2024 | $190M | -$51M | 5.9% | -22.7% | -$38M | — | $3M |
| 2023 | $300M | -$20M | 1.2% | -17.3% | -$41M | $312M | $14M |
| 2022 | $258M | -$23M | 2.9% | -17.0% | -$136M | $233M | $20M |
| 2021 | $100M | -$64M | -2.5% | -84.1% | -$171M | $313M | $29M |
| 2019 | $228M | -$285M | 56.6% | -81.4% | -$178M | $504M | $69M |
| 2018 | $483M | -$224M | 65.6% | -77.4% | -$352M | $1.1B | $117M |
How the market has priced UXIN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Uxin Ltd's revenue has grown 46.6% per year. These are computed facts, not advice.
As of FY2025, Uxin Ltd reported — of total debt against $12M of cash; operating income covered interest expense -1.8×.
In FY2025, gross margin was 6.7%, operating margin -5.4%, and net margin -8.1%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.